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When treating more complex target volumes, like pelvic nodes (Type 
2), we could not achieve better dose distributions with the SS method, 
namely in terms of OARs sparing and we were not able to take 
advantage of the reduced number of segments and MU, associated 
with the SS method. 
No significant differences were found in terms of IMRT QA.  
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Purpose/Objective: Objective of the present work is to evaluate the 
influence of increase in dose rate on dynamic IMRT plan quality and 
deliverability. 
Materials and Methods: Three previously treated patients of 
carcinoma prostate were chosen. Planning target volume (PTV) and 
organ at risk (OAR) i.e. bladder and rectum were contoured. Dynamic 
SIB-IMRT plans were created in Eclipse treatment planning system 
(TPS) for Varian CL2300C/D linear accelerator. Seven equi-spaced 
fields with 6MV photon beam at 300MU/min dose rate with 2.5cm/sec 
maximum allowable leaf velocity was used. The plan was then re-
optimized by keeping all the parameters constant, only dose rate was 
varied as follows: 400MU/min, 500MU/min and 600MU/min. 
Therefore, for each patient, four different plans were created. 
Prescription dose was 74Gy for PTV primary(PTV-P) and 54Gy for PTV 
Nodal (PTV-N) in 27 fractions and dose was prescribed at 95% isodose 
line. Plan quality was analyzed by means maximum and mean doses of 
PTV and OAR. Normal tissue integral dose (N.T.I.D.) (liter-Gray) of 
normal tissue volume (i.e., patient volume minus PTV-P and PTV-PA) 
was also calculated. Dose rate of 300MU/min was taken as reference. 
For accuracy of deliverability, treatment plans were verified with 
I’matriXX ion-chamber array and compared with TPS dose-plane by 
using gamma (γ) index of 3% dose difference and 3mm distance to 
agreement (DTA) criteria. Percentage of pixels passing gamma value 
up to 1(γ% ≤1) were noted. In addition, total monitor units (MUs) 
required to deliver a plan and machine beam ON time (min) were also 
noted. 
Results 
Results are summarized in Table-1 
 
Conclusions: There is no much dose difference was found for the PTV. 
However, slight difference was found for PTV-N maximum and mean 
doses. Similarly,increase in bladder mean dose, NTID and total 
number of MU increased with increase in dose rate. Beam ON time 
was lesser for higher dose rate. 2D gamma analysis showed almost 
comparable results for all dose rates.  
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Purpose/Objective: In 3D image-guided HDR gynaecological 
brachytherapy treatments, a consequence of the small size of the192Ir 
sources that are used for treatment combined with a steep dose 
gradient is that precise determination of source dwell positions 
becomes critical for accurate reconstruction of ring applicators. In 
comparison to CT and MRI which only allow for indirect reconstruction 
of applicators and consequent increase in associated reconstruction 
uncertainty, the use of film enables direct reconstruction of source 
dwell positions. This paper details a methodology and associated 
uncertainties relating to the reconstruction of ring applicators using 
gafchromic film. 
Materials and Methods: RTQA2 gafchromic films were attached to the 
surface of Nucletron interstitial ring applicators and irradiated at pre-
programmed dwell positions 1 cm apart in the configuration shown in 
figure 1. Four, three and one sets of Ø26 mm, Ø30 mm, and Ø34 mm 
ring applicators respectively were used for this study. The irradiated 
films were digitized using an Epson Expression 10000XL scanner. The 
coordinates of the source dwell positions were identified and the 
source path for the rings characterized by investigating correlations 
between the source path and movement of the source cable. 
Measurements were repeated over a period of nine months using three 
consecutive 192Ir sources and inter applicator and inter source dwell 
position differences investigated.  
 
  
Results: The source path was observed to deviate from the cable path 
by up to 30% leading to a cumulative deviation in expected source 
dwell position of at least 5 mm in all ring applicators. The inter 
applicator and inter source differences in source dwell positions were 
observed to be within the associated measurement uncertainties for 
the Ø30 mm and Ø34 mm ring applicators. Significant differences 
were observed between sets of the Ø26 mm ring applicators. The total 
expanded uncertainties associated with the determination of source 
positions in the applicators and presented in table 1, showed a 
maximum intra applicator average total expanded uncertainty (k=2) of 
1.14 ± 0.30 mm, 1.19 ± 0.14 mm and 1.04 ± 0.30 mm for the Ø26 mm, 
Ø30 mm and Ø34 mm ring applicator sets respectively. The inter 
applicator average total expanded unceratinty was also observed to 
be 1.07 ± 0.11 mm and 1.09 ±0.05 mm for the Ø26 mm and Ø30 mm 
ring applicators. 
 
PATIENT Patient 1 Patient 2 Patient 3  
DOSE 
RATE 
RATIO 
300 
300 
400 
300 
500 
300 
600 
300 
300 
300 
400 
300 
500 
300 
600 
300 
300 
300 
400 
300 
500 
300 
600 
300 
PTV-P 
MAX. 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.001 1.000 
PTV-P 
MEAN 1.000 0.999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.001 
PTV-N 
MAX. 1.000 1.000 1.000 1.001 1.000 1.001 1.002 1.002 1.000 0.999 0.999 1.000 
PTV-N 
MEAN 1.000 1.000 1.000 1.001 1.000 1.000 1.000 1.001 1.000 1.000 1.000 1.001 
BLADDER 
MAX 1.000 1.000 1.000 1.001 1.000 0.999 1.000 1.000 1.000 1.000 1.000 1.000 
BLADDER 
MEAN 1.000 1.000 1.002 1.003 1.000 1.001 1.002 1.003 1.000 1.001 1.003 1.005 
RECTUM 
MAX 1.000 1.000 1.000 1.001 1.000 0.999 1.000 1.000 1.000 1.000 1.002 1.002 
RECTUM 
MEAN 1.000 1.000 1.000 1.001 1.000 1.000 1.001 1.002 1.000 1.001 1.001 1.002 
N .T. 
I. D. 1.000 1.003 1.006 1.009 1.000 1.003 1.006 1.009 1.000 1.002 1.005 1.007 
PATIENT Patient 1 Patient 2 Patient 3  DOSE 
RATE 300 400 500 600 300 400 500 600 300 400 500 600 
TOTAL 
MU 
1565 
MU 
1931 
MU 
2024 
MU 
2112 
MU 
2254 
MU 
2337 
MU 
2426 
MU 
2513 
MU 
2322 
MU 
2389 
MU 
2468 
MU 
2552 
MU 
BEAM ON 
TIME  
6.78 
min. 
5.35 
min. 
4.43 
min. 
4.01 
min. 
7.80 
min. 
6.25 
min. 
5.15 
min. 
4.28 
min. 
7.83 
min. 
6.18 
min. 
5.10 
min. 
4.45 
min. 
γ INDEX 
(γ% ≤1) 
98.97 
% 
99.11
% 
98.95 
% 
99.02 
% 
99.78
% 
99.87 
% 
99.56 
% 
99.68
% 
99.48 
% 
99.39 
% 
99.44
% 
99.44 
% 
